These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection. Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276 [TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559 [TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase. Zhang X; Dong Y; Zeng X; Li Y; Tang F Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882 [TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis. Russell KA; Fass DN; Specks U Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478 [TBL] [Abstract][Full Text] [Related]
12. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Radice A; Vecchi M; Bianchi MB; Sinico RA Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537 [TBL] [Abstract][Full Text] [Related]
14. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis]. Csernok E; Reichel P; Gross WL Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969 [TBL] [Abstract][Full Text] [Related]
16. [New aspects in ANCA-associated vasculitides]. Lamprecht P Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181 [TBL] [Abstract][Full Text] [Related]
17. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Liu LJ; Chen M; Yu F; Zhao MH; Wang HY Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059 [TBL] [Abstract][Full Text] [Related]
18. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population. Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885 [TBL] [Abstract][Full Text] [Related]